Tag - health

 
 

HEALTH

Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
WORLD / Science & Health
Nov 21, 2020
The coronavirus is airborne indoors, but we’re still scrubbing surfaces
Scientists who initially warned about contaminated surfaces now say here is little to no evidence that deep cleaning mitigates the threat indoors.
Japan Times
JAPAN
Nov 20, 2020
This virus expert saved Japan from the worst of COVID-19. But has the magic worn off?
Those who worked with Hitoshi Oshitani say his early sense of urgency, constantly badgering government officials to do more, has been crucial to Japan's novel coronavirus response.
Japan Times
COMMENTARY / World
Nov 20, 2020
What COVID-19 is costing women?
The pandemic has compounded a longstanding problem for women around the world: large and persistent barriers to participating in the economy and public life on an equal basis with men.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
WORLD / Science & Health
Nov 20, 2020
Wildlife diseases poised to spread northwards as climate changes
As the world’s climate warms, parasite-carried wildlife diseases will move north, with animals in cold far-north and high-altitude regions expected to suffer the most dramatic increases, warns a study published on Friday in the journal Science.
Japan Times
COMMENTARY / World
Nov 19, 2020
COVID-19 mutated. Can vaccines keep up?
So far, scientists have found only one mutation that improves the survival ability of the virus. The more transmissible strain is referred to as G614.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
COMMENTARY / Japan
Nov 18, 2020
Can Japan bridge the vaccine divide?
Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Politics
Nov 18, 2020
Biden names top White House aides as doctors urge Trump to cooperate on COVID-19
President-elect Joe Biden on Tuesday named several senior staffers for his White House, while his top coronavirus advisers warned that President Donald Trump's stalling of the official transition could compromise the country's pandemic response.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
COMMENTARY / World
Nov 16, 2020
A vaccine won't derail the easy money train
Don't get carried away by the good news on vaccine development. Central banks are miles from the exit ramp for the tremendous stimulus they've pumped into the economy.
Japan Times
WORLD
Nov 16, 2020
U.S. doctors are calling it quits under stress of the pandemic
Thousands of medical practices have closed during the pandemic, according to a July survey of 3,500 doctors by the Physicians Foundation, a nonprofit group.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?